
A judge in New Jersey has given the go-ahead for what could be multi-billion dollar litigation surrounding insulin companies and the alleged over-inflated prices charged to consumers for the insulin they manufacture.In court documents released Wednesday, U.S. District Court Judge Brian R. Martinotti established a leadership structure to control and manage the litigation across the entire multi-district litigation (MDL) involving Insulin costs in the U.S.Among the names announced was Miami attorney Benjamin J. Widlanski, chosen to be Co-lead on one of the three tracks the case has been divided into.
Biotech & Pharmaceuticals
December 08, 2023, 3:38 PM